收费全文 | 11074篇 |
免费 | 903篇 |
国内免费 | 24篇 |
耳鼻咽喉 | 66篇 |
儿科学 | 334篇 |
妇产科学 | 235篇 |
基础医学 | 1417篇 |
口腔科学 | 549篇 |
临床医学 | 1075篇 |
内科学 | 1785篇 |
皮肤病学 | 167篇 |
神经病学 | 797篇 |
特种医学 | 352篇 |
外国民族医学 | 2篇 |
外科学 | 1109篇 |
综合类 | 68篇 |
一般理论 | 3篇 |
预防医学 | 2607篇 |
眼科学 | 92篇 |
药学 | 700篇 |
中国医学 | 23篇 |
肿瘤学 | 620篇 |
2023年 | 76篇 |
2022年 | 109篇 |
2021年 | 143篇 |
2020年 | 182篇 |
2019年 | 166篇 |
2018年 | 241篇 |
2017年 | 226篇 |
2016年 | 224篇 |
2015年 | 204篇 |
2014年 | 281篇 |
2013年 | 477篇 |
2012年 | 431篇 |
2011年 | 446篇 |
2010年 | 329篇 |
2009年 | 350篇 |
2008年 | 437篇 |
2007年 | 391篇 |
2006年 | 430篇 |
2005年 | 409篇 |
2004年 | 355篇 |
2003年 | 287篇 |
2002年 | 367篇 |
2001年 | 335篇 |
2000年 | 327篇 |
1999年 | 388篇 |
1998年 | 240篇 |
1997年 | 282篇 |
1996年 | 266篇 |
1995年 | 208篇 |
1994年 | 116篇 |
1993年 | 186篇 |
1992年 | 201篇 |
1991年 | 213篇 |
1990年 | 203篇 |
1989年 | 206篇 |
1988年 | 209篇 |
1987年 | 208篇 |
1986年 | 211篇 |
1985年 | 196篇 |
1984年 | 116篇 |
1983年 | 133篇 |
1982年 | 91篇 |
1981年 | 90篇 |
1980年 | 71篇 |
1979年 | 115篇 |
1978年 | 98篇 |
1977年 | 90篇 |
1976年 | 73篇 |
1975年 | 67篇 |
1974年 | 64篇 |
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.Main outcome measures In all subjects expiratory volumes were determined and urinary analysis was conducted for hydroxyproline, calcium, phosphorus, and cortisol levels. Osteocalcin, calcium, phosphorus, cortisol, alkaline phosphatase, and γ-glutamyltransferase levels were measured in blood samples. Bone density of the lumbar spine was determined by means of dual-energy x-ray absorptiometry. Nutrition evaluation was based on a 3-day food diary analyzed using progiciel Nutri 91. The nutritional parameters examined were calcium; phosphorus; magnesium; zinc; vitamins A, C, and D; protein; total fiber; oxalates; energy; caffeine; and alcohol in relation to bone density.
Subjects Thirty-one patients with moderate to severe asthma who had been taking more than 1,000 μg beclomethasone per day or the equivalent for more than 2 years and 27 patients with mild asthma who were taking less than 500 μg beclomethasone per day or the equivalent.
Statistical analyses performed Four factor analysis of variance with hierarchized interactions of four levels, Duncan's test, Pearson correlation coefficients.
Results Blood levels of osteocalcin and protein intake were lower in patients with moderate to severe asthma than in those with mild asthma (P<.05). Significant correlations (P<.02) were observed between bone density and calcium intake (r=.40), phosphorus intake (r=.35), protein intake (r=.30), and serum alkaline phosphatase level (r=−.30). Bone density was not significantly different between the two groups of patients with asthma.
Applications A follow-up of patients with asthma who are taking inhaled corticosteroids is needed to assess bone density, osteocalcin levels, and dietary intakes of calcium. Verify if osteocalcin level decreases over time in patients with moderate to severe asthma, monitor possible modifications in bone density, and verify if the correlation between dietary calcium and bone density is maintained. J Am Diet Assoc. 1997;97:1401–1406. 相似文献